SCHEDULE 13G/A: Wealthspring Capital LLC and Matthew Simpson Report Full Divestment of Aimei Health Technology Shares
Beneficial Ownership Amendment
Wealthspring Capital LLC and Matthew Simpson have reported a 0% beneficial ownership in Aimei Health Technology Co., LTD as of December 31, 2024, indicating a full divestment of their previously held stake.
Summary
- Wealthspring Capital LLC and Matthew Simpson, the reporting persons, filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership in Aimei Health Technology Co., LTD.
- As of December 31, 2024, both Wealthspring Capital LLC and Matthew Simpson report beneficial ownership of 0 shares of Aimei Health Technology Co., LTD's Ordinary Shares.
- This represents 0% of the class of securities, indicating they no longer hold a reportable stake.
- The filing certifies that the securities (if any were held) were acquired and held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: Neutral. The document is a routine regulatory filing reporting a change in beneficial ownership to zero, which is a factual update without explicit positive or negative implications for the company's operations or financial health within this document.
Future Outlook
NA
Industry Context
NA
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires filing of this statement (reporting period end date). |
| 02/10/2025 | Date of signing the Schedule 13G Amendment No. 1. |
Keywords
Aimei Health Technology, Wealthspring Capital LLC, Matthew Simpson, Schedule 13G, beneficial ownership, divestment, SEC filing, ordinary shares
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.